OTIPRIO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Otiprio, and when can generic versions of Otiprio launch?
Otiprio is a drug marketed by Alk Abello and is included in one NDA. There are eight patents protecting this drug.
This drug has one hundred and fifty patent family members in twenty countries.
The generic ingredient in OTIPRIO is ciprofloxacin. There are thirty-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ciprofloxacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Otiprio
A generic version of OTIPRIO was approved as ciprofloxacin by BAXTER HLTHCARE CORP on April 29th, 2008.
Summary for OTIPRIO
International Patents: | 150 |
US Patents: | 8 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 123 |
Clinical Trials: | 4 |
Patent Applications: | 4,524 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for OTIPRIO |
What excipients (inactive ingredients) are in OTIPRIO? | OTIPRIO excipients list |
DailyMed Link: | OTIPRIO at DailyMed |
Recent Clinical Trials for OTIPRIO
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Boston Medical Center | Phase 4 |
Otonomy, Inc. | Phase 2 |
Otonomy, Inc. | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for OTIPRIO
US Patents and Regulatory Information for OTIPRIO
OTIPRIO is protected by eight US patents.
Patents protecting OTIPRIO
Otic gel formulations for treating otitis externa
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: THE TREATMENT OF ACUTE OTITIS EXTERNA IN PATIENTS 6 MONTHS OF AGE AND OLDER DUE TO PSEUDOMONAS AERUGINOSA AND STAPHYLOCOCCUS AUREUS
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF OTIC INFECTION OR INFLAMMATION
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF PEDIATRIC PATIENTS WITH OTITIS MEDIA WITH EFFUSION UNDERGOING TYMPANOSTOMY TUBE PLACEMENT
Sterilization of ciprofloxacin composition
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: THE TREATMENT OF ACUTE OTITIS EXTERNA IN PATIENTS 6 MONTHS OF AGE AND OLDER DUE TO PSEUDOMONAS AERUGINOSA AND STAPHYLOCOCCUS AUREUS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alk Abello | OTIPRIO | ciprofloxacin | INJECTABLE, SUSPENSION;OTIC | 207986-001 | Dec 10, 2015 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alk Abello | OTIPRIO | ciprofloxacin | INJECTABLE, SUSPENSION;OTIC | 207986-001 | Dec 10, 2015 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Alk Abello | OTIPRIO | ciprofloxacin | INJECTABLE, SUSPENSION;OTIC | 207986-001 | Dec 10, 2015 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alk Abello | OTIPRIO | ciprofloxacin | INJECTABLE, SUSPENSION;OTIC | 207986-001 | Dec 10, 2015 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Alk Abello | OTIPRIO | ciprofloxacin | INJECTABLE, SUSPENSION;OTIC | 207986-001 | Dec 10, 2015 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Alk Abello | OTIPRIO | ciprofloxacin | INJECTABLE, SUSPENSION;OTIC | 207986-001 | Dec 10, 2015 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alk Abello | OTIPRIO | ciprofloxacin | INJECTABLE, SUSPENSION;OTIC | 207986-001 | Dec 10, 2015 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for OTIPRIO
See the table below for patents covering OTIPRIO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2011528716 | ⤷ Try a Trial | |
Canada | 2732686 | COMPOSITIONS DE MODULATEUR DE CELLULES SENSORIELLES AURICULAIRES A LIBERATION CONTROLEE ET PROCEDES DE TRAITEMENT DE TROUBLES OTIQUES (CONTROLLED RELEASE AURIS SENSORY CELL MODULATOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS) | ⤷ Try a Trial |
Japan | 6014069 | ⤷ Try a Trial | |
Taiwan | I450732 | ⤷ Try a Trial | |
European Patent Office | 2299979 | COMPOSITIONS ANTIMICROBIENNES À LIBÉRATION CONTRÔLÉE ET PROCÉDÉS POUR LE TRAITEMENT DE TROUBLES OTIQUES (CONTROLLED RELEASE ANTIMICROBIAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS) | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2018053173 | ⤷ Try a Trial | |
Australia | 2019275578 | Sterilization of ciprofloxacin composition | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OTIPRIO
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1429780 | 122012000070 | Germany | ⤷ Try a Trial | PRODUCT NAME: KOMBINATION AUS CIPROFLOXACIN UND DEXAMETHASON, INSBESONDERE CIPROFLOXACINHYDROCHLORID UND DEXAMETHASON; NAT. REGISTRATION NO/DATE: 85150.00. 00 20120830; FIRST REGISTRATION: DAENEMARK 48976 20120808 |
1429780 | SPC/GB12/058 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
1429780 | 132013902137451 | Italy | ⤷ Try a Trial | PRODUCT NAME: CIPROFLOXACINA E DESAMETASONE(CILODEX); AUTHORISATION NUMBER(S) AND DATE(S): 48976, 20120810;041182015/M, 20121106 |
1429780 | 13C0012 | France | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |